Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Pfizer Acquires Medivation for $14 Billion

Pfizer Inc. – beating out numerous other bidders – said it would buy U.S. cancer drug company Medivation Inc. for $14 billion in cash.

Read More »

FDA Delays Sanofi’s Potential New Diabetes Drug

New timelines were announced for a U.S. FDA decision on Iglarlixi, the fixed-ratio combination of Adlyxin (lixisenatide) and Lantus, for treating type 2 diabetes.

Read More »

Google’s Verily HQ in the Peninsula Needs More Time, Company Seeks Timeline Extension

Verily, Google’s life sciences division, needs more time to complete the construction of its new campus in the Bay Area.

Read More »

DS Biopharma Spins Out New Company Focused on Fibrotic Conditions and Pulmonary Disorders

Privately held DS Biopharma is spinning out a new company called Afimmune that is focused solely on fibrotic conditions such as NASH and pulmonary disorders including COPD and IPF.

Read More »

D.A. Henderson, who led effort to eradicate smallpox, dies at 87

Donald A. Henderson, who headed the World Health Organization vaccination effort that wiped out smallpox in 1977 and later became a U.S. bioterrorism expert, has died from complications following a hip fracture, officials said.

Read More »

Health official warns Zika could spread across U.S. Gulf

One of the top U.S. public health officials warned that the mosquito-borne Zika virus could extend its reach across the U.S. Gulf Coast after officials confirmed it as active in the popular tourist destination of Miami Beach.

Read More »

China over-reliant on hospitals, needs more family doctors: WHO

China’s healthcare system is overly reliant on large over-burdened hospitals, which will struggle to cope with a spike in diseases linked to the fast-aging population, the World Health Organization said.

Read More »

Korean Firms Acquire Novo Nordisk’s U.S. HQ

A Korean investment firm along with three South Korean securities firms has snapped up the North American headquarters of Novo Nordisk for $305 million.

Read More »

Bayer, CRISPR Form Joint Venture Named Casebia

Casebia Therapeutics, a joint venture between Bayer and CRISPR Therapeutics, plans to open laboratory and office space in Cambridge, Mass.

Read More »

FDA widens use of Edwards’ devices for heart valve replacement

The U.S. Food and Drug Administration has widened the use of Edwards Lifesciences’ heart valves to patients at intermediate risk of complications if they underwent open heart surgery.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom